Tag Archives: Dr Ellis Unger

US FDA approves new orphan drug to treat pulmonary arterial hypertension

Washington: The US Food and Drug Administration on Monday approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive, and debilitating rare lung disease that can lead to death or the need for transplantation.

Posted in NEWS, Pharmaceuticals | Tagged , , , , , , | Leave a comment

FDA approves Zontivity to reduce risk of heart attacks and stroke in high-risk patients

Washington: The US Food and Drug Administration has approved Zontivity (vorapaxar) tablets to reduce the risk of heart attack, stroke, cardiovascular death, and need for procedures to restore the blood flow to the heart in patients with a previous heart attack or blockages in the arteries to the legs.

Posted in NEWS, Pharmaceuticals | Tagged , , , , , | Leave a comment